NASDAQ:SRTS Sensus Healthcare (SRTS) Stock Price, News & Analysis → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free SRTS Stock Alerts $3.80 -0.12 (-3.06%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$3.80▼$3.9350-Day Range$2.61▼$4.9152-Week Range$1.79▼$5.38Volume51,211 shsAverage Volume161,478 shsMarket Capitalization$62.28 millionP/E Ratio126.71Dividend YieldN/APrice Target$7.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Sensus Healthcare alerts: Email Address Sensus Healthcare MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside97.4% Upside$7.50 Price TargetShort InterestHealthy0.51% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.58 out of 5 starsMedical Sector506th out of 938 stocksSurgical & Medical Instruments Industry57th out of 94 stocks 3.5 Analyst's Opinion Consensus RatingSensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $7.50, Sensus Healthcare has a forecasted upside of 97.4% from its current price of $3.80.Amount of Analyst CoverageSensus Healthcare has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.51% of the float of Sensus Healthcare has been sold short.Short Interest Ratio / Days to CoverSensus Healthcare has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sensus Healthcare has recently increased by 166.40%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSensus Healthcare does not currently pay a dividend.Dividend GrowthSensus Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SRTS. Previous Next 2.6 News and Social Media Coverage News SentimentSensus Healthcare has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Sensus Healthcare this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for SRTS on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days.MarketBeat Follows6 people have added Sensus Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sensus Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders11.10% of the stock of Sensus Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 25.30% of the stock of Sensus Healthcare is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sensus Healthcare is 126.71, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 148.82.Price to Earnings Ratio vs. SectorThe P/E ratio of Sensus Healthcare is 126.71, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 275.18.Price to Book Value per Share RatioSensus Healthcare has a P/B Ratio of 1.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About Sensus Healthcare Stock (NASDAQ:SRTS)Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and TransDermal Infusion system. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body, as well as distributes laser devices. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.Read More SRTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SRTS Stock News HeadlinesMarch 23, 2024 | wsj.comSensus Healthcare Inc.March 14, 2024 | globenewswire.comSensus Healthcare to Participate in the 36th Annual Roth ConferenceMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.March 13, 2024 | globenewswire.comSensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual MeetingMarch 11, 2024 | realmoney.thestreet.comA Market With a HangoverFebruary 25, 2024 | investorplace.com3 Stocks to Buy That Are Up 100% or More in 2024February 24, 2024 | msn.comSensus Healthcare (SRTS) Price Target Increased by 24.07% to 6.83February 23, 2024 | benzinga.comSensus Healthcare Stock (NASDAQ:SRTS) Earnings Dates and Earning CallsMarch 29, 2024 | Crypto 101 Media (Ad)Top Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.February 21, 2024 | realmoney.thestreet.comMy Current Game Plan Includes Adding This Small-Cap Stock to My Watch ListFebruary 12, 2024 | finance.yahoo.comInteger Holdings Corporation (ITGR) Soars to 52-Week High, Time to Cash Out?February 11, 2024 | finance.yahoo.comSensus Healthcare, Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesFebruary 10, 2024 | markets.businessinsider.comSensus Healthcare: Strong Q4 Performance and Promising Future Drive Buy RatingFebruary 9, 2024 | seekingalpha.comSensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call TranscriptFebruary 9, 2024 | finance.yahoo.comSensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2023 Earnings Call TranscriptFebruary 9, 2024 | finance.yahoo.comQ4 2023 Sensus Healthcare Inc Earnings CallFebruary 8, 2024 | markets.businessinsider.comSensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 8, 2024 | msn.comSensus Healthcare announces U.S. patent for SRT-100 Vision SystemFebruary 8, 2024 | finance.yahoo.comSensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) CapabilitiesFebruary 7, 2024 | benzinga.comEarnings Preview For Sensus HealthcareFebruary 6, 2024 | finance.yahoo.comSensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory RequirementsFebruary 3, 2024 | msn.comSensus Healthcare Announces Director Samuel O’Rear’s RetirementFebruary 2, 2024 | realmoney.thestreet.comApple, Amazon and Meta Will Tell Us a Lot About This Market's HealthFebruary 1, 2024 | finance.yahoo.comInogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?February 1, 2024 | finance.yahoo.comSensus Healthcare Announces Retirement of Director Samuel O’RearJanuary 30, 2024 | finance.yahoo.comSensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024January 25, 2024 | markets.businessinsider.comBuy Rating Affirmed for Sensus Healthcare Amidst Strong Performance and Growth ProspectsSee More Headlines Receive SRTS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/08/2024Today3/29/2024Next Earnings (Estimated)5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SRTS CUSIPN/A CIK1494891 Webwww.sensushealthcare.com Phone(561) 922-5808Fax561-948-2071Employees42Year FoundedN/APrice Target and Rating Average Stock Price Target$7.50 High Stock Price Target$8.00 Low Stock Price Target$7.00 Potential Upside/Downside+97.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio126.71 Forward P/E Ratio47.50 P/E GrowthN/ANet Income$490,000.00 Net Margins1.99% Pretax Margin2.67% Return on Equity1.04% Return on Assets0.93% Debt Debt-to-Equity RatioN/A Current Ratio11.76 Quick Ratio8.23 Sales & Book Value Annual Sales$24.41 million Price / Sales2.55 Cash Flow$0.05 per share Price / Cash Flow69.10 Book Value$2.98 per share Price / Book1.28Miscellaneous Outstanding Shares16,390,000Free Float14,574,000Market Cap$62.28 million OptionableOptionable Beta0.92 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Joseph C. Sardano (Age 71)Co-Founder, Chairman & CEO Comp: $754.43kMr. Michael J. Sardano (Age 35)President, General Counsel, Corporate Secretary & Director Comp: $404.74kMr. Javier Rampolla (Age 51)Chief Financial Officer Comp: $439.14kMs. Magdalena Martinez (Age 34)Chief Operating Officer Mr. Emiliano Sosa (Age 46)Chief Technology Officer Sean DelaneyVice President of Regulatory Affairs & ComplianceMs. Stephanie TiptonVice President of MarketingDr. Mark S. NestorMedical Director & Member of Medical Advisory BoardDr. Clay Jefferies Cockerell (Age 67)Clinical Director & Member of Medical Advisory Board More ExecutivesKey CompetitorsGBSNYSE:GBSBeyond AirNASDAQ:XAIRPro-DexNASDAQ:PDEXSEP AcquisitionNASDAQ:SEPAMonogram OrthopaedicsNASDAQ:MGRMView All CompetitorsInsiders & InstitutionsCreekmur Asset Management LLCBought 35,192 shares on 3/1/2024Ownership: 0.215%Nantahala Capital Management LLCSold 8,298 shares on 2/15/2024Ownership: 1.079%Perritt Capital Management Inc.Bought 25,000 shares on 2/15/2024Ownership: 0.797%Northern Trust CorpBought 39,040 shares on 2/13/2024Ownership: 0.379%Sachetta LLCBought 104,810 shares on 2/9/2024Ownership: 0.640%View All Insider TransactionsView All Institutional Transactions SRTS Stock Analysis - Frequently Asked Questions Should I buy or sell Sensus Healthcare stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SRTS shares. View SRTS analyst ratings or view top-rated stocks. What is Sensus Healthcare's stock price target for 2024? 1 brokerages have issued 1-year price objectives for Sensus Healthcare's stock. Their SRTS share price targets range from $7.00 to $8.00. On average, they expect the company's stock price to reach $7.50 in the next year. This suggests a possible upside of 97.4% from the stock's current price. View analysts price targets for SRTS or view top-rated stocks among Wall Street analysts. How have SRTS shares performed in 2024? Sensus Healthcare's stock was trading at $2.36 at the beginning of 2024. Since then, SRTS stock has increased by 61.0% and is now trading at $3.80. View the best growth stocks for 2024 here. Are investors shorting Sensus Healthcare? Sensus Healthcare saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 65,800 shares, an increase of 166.4% from the February 29th total of 24,700 shares. Based on an average daily trading volume, of 165,400 shares, the short-interest ratio is presently 0.4 days. Currently, 0.5% of the shares of the company are short sold. View Sensus Healthcare's Short Interest. When is Sensus Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024. View our SRTS earnings forecast. How were Sensus Healthcare's earnings last quarter? Sensus Healthcare, Inc. (NASDAQ:SRTS) issued its quarterly earnings results on Thursday, February, 8th. The company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.14. The company earned $12.57 million during the quarter, compared to analyst estimates of $12.10 million. Sensus Healthcare had a net margin of 1.99% and a trailing twelve-month return on equity of 1.04%. What guidance has Sensus Healthcare issued on next quarter's earnings? Sensus Healthcare updated its fourth quarter 2023 earnings guidance on Tuesday, January, 23rd. The company provided EPS guidance of for the period. The company issued revenue guidance of $12.0 million-, compared to the consensus revenue estimate of $7.5 million. What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM). When did Sensus Healthcare IPO? Sensus Healthcare (SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at a price of $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. Who are Sensus Healthcare's major shareholders? Sensus Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Nantahala Capital Management LLC (1.08%), Perritt Capital Management Inc. (0.80%), Sachetta LLC (0.64%), Dimensional Fund Advisors LP (0.42%), Northern Trust Corp (0.38%) and Creekmur Asset Management LLC (0.21%). Insiders that own company stock include Javier Rampolla, John Heinrich, Joseph C Sardano, Michael Sardano, Nicolas Soro, Samuel O'rear, Stephen Brad Cohen and William H Mccall. View institutional ownership trends. How do I buy shares of Sensus Healthcare? Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SRTS) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.